Fundraising Fox

MapLight Therapeutics

NASDAQ: MPLT

Redwood City, US · Founded 2018 · Delaware corporation · 1 known investors

Biotech

Founders & leadership

KH
Kristopher HansonExecutive Officer
TG
Timothy GarnettDirector
GP
George PavlovDirector
PB
Peter BisgaardDirector
EF
Erin FoffExecutive Officer
AK
Anatol KreitzerExecutive Officer
JT
Jim TrenkleDirector
JL
James LillieExecutive Officer
MW
Maria WalkerDirector
CA
Christopher A KroegerExecutive Officer, Director
JG
Jonathan GillisExecutive Officer
VS
Vishwas SetiaExecutive Officer

Investors · 1

ForbionreportedNaardenvia Nanna Luneborg · board

Reported raises · per SEC filings

Form D private placements
▶$188.2MraisedJul 2025 · 19 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kristopher HansonExecutive Officer
  • Timothy GarnettDirector
  • George PavlovDirector
  • Peter BisgaardDirector
  • Erin FoffExecutive Officer
  • Anatol KreitzerExecutive Officer
  • Jim TrenkleDirector
  • James LillieExecutive Officer
  • Maria WalkerDirector
  • Christopher A KroegerExecutive Officer, Director
  • Jonathan GillisExecutive Officer
  • Vishwas SetiaExecutive Officer
  • Nanna LuneborgDirector
Offering amount
$372.4M
Amount sold
$188.2M
First sale
Jul 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$105MraisedNov 2023 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert MalenkaDirector
  • Jim TrenkleDirector
  • Peter BisgaardDirector
  • Kristopher HansonExecutive Officer
  • George PavlovDirector
  • Charmaine LykinsExecutive Officer
  • Anatol KreitzerExecutive Officer
  • Erin FoffExecutive Officer
  • Jonathan GillisExecutive Officer
  • James LillieExecutive Officer
  • Timothy GarnettDirector
  • Christopher A KroegerExecutive Officer, Director
Offering amount
$225M
Amount sold
$105M
First sale
Jul 2023
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$12MraisedNov 2022 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Peter BisgaardDirector
  • Christopher A KroegerExecutive Officer, Director
  • Erin FoffExecutive Officer
  • James LillieExecutive Officer
  • George PavlovDirector
  • Robert MalenkaDirector
  • Anatol KreitzerExecutive Officer
  • Jonathan GillisExecutive Officer
Offering amount
$12M
Amount sold
$12M
First sale
Oct 2022
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$30MraisedMar 2021 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Christopher A KroegerExecutive Officer, Director
  • George PavlovDirector
  • Robert MalenkaDirector
  • Anatol KreitzerExecutive Officer
  • Peter BisgaardDirector
  • Jonathan GillisExecutive Officer
  • James LillieExecutive Officer
Offering amount
$60M
Amount sold
$30M
First sale
Feb 2021
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$16MraisedSep 2019 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jonathan GillisExecutive Officer
  • Peter BisgaardDirector
  • James LillieExecutive Officer
  • Robert MalenkaDirector
  • Christopher A KroegerExecutive Officer, Director
  • George PavlovDirector
Offering amount
$16M
Amount sold
$16M
First sale
Aug 2019
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedMar 2019 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Christopher A KroegerExecutive Officer, Director
  • Robert MalenkaDirector
  • James LillieExecutive Officer
  • George PavlovDirector
  • Peter BisgaardDirector
  • Jonathan GillisExecutive Officer
Offering amount
$5M
Amount sold
$5M
First sale
Feb 2019
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.